IRIS
FERRARI, GIULIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.002
AS - Asia 1.806
NA - Nord America 1.312
SA - Sud America 320
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 5.485
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.326
US - Stati Uniti d'America 1.237
SG - Singapore 656
CN - Cina 537
BR - Brasile 253
IT - Italia 216
HK - Hong Kong 188
VN - Vietnam 147
FR - Francia 105
BD - Bangladesh 102
SE - Svezia 80
TR - Turchia 57
DE - Germania 55
GB - Regno Unito 52
CA - Canada 37
FI - Finlandia 34
NL - Olanda 32
IN - India 28
AR - Argentina 26
MX - Messico 22
IE - Irlanda 17
ZA - Sudafrica 17
JP - Giappone 16
ES - Italia 14
AT - Austria 11
BG - Bulgaria 11
EC - Ecuador 11
CH - Svizzera 9
IQ - Iraq 9
PK - Pakistan 9
PL - Polonia 9
CL - Cile 8
CO - Colombia 8
BE - Belgio 6
IR - Iran 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
MY - Malesia 5
PH - Filippine 5
PY - Paraguay 5
RO - Romania 5
SA - Arabia Saudita 5
UA - Ucraina 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
ID - Indonesia 4
JM - Giamaica 4
TN - Tunisia 4
VE - Venezuela 4
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
CU - Cuba 2
DZ - Algeria 2
KR - Corea 2
PE - Perù 2
PS - Palestinian Territory 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KE - Kenya 1
KZ - Kazakistan 1
MD - Moldavia 1
MR - Mauritania 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.485
Salva come PNG Salva come JPEG
Città #
Singapore 301
Moscow 293
Ashburn 219
Hong Kong 177
San Jose 159
Dallas 150
Shanghai 79
Lauterbourg 77
Milan 74
Hefei 68
Beijing 67
Ho Chi Minh City 62
New York 54
Istanbul 49
Los Angeles 44
Hanoi 38
Lawrence 37
Princeton 37
Amsterdam 24
Council Bluffs 23
Rome 23
Santa Clara 22
Helsinki 21
Rio de Janeiro 20
Xi'an 19
Orem 18
Dublin 17
Brooklyn 16
Chicago 16
São Paulo 16
London 15
Chennai 12
Boston 11
Guangzhou 11
Nuremberg 11
Porto Alegre 11
Atlanta 10
Johannesburg 10
Montreal 10
Poplar 10
Tokyo 10
Houston 9
Munich 9
Stockholm 9
Warsaw 9
Boardman 8
Buffalo 8
Mexico City 8
Omaha 8
Paris 7
Phoenix 7
Quito 7
Bologna 6
Charlotte 6
Falkenstein 6
Frankfurt am Main 6
Lappeenranta 6
San Francisco 6
Shenzhen 6
Sofia 6
Toronto 6
Turku 6
Washington 6
Ankara 5
Baghdad 5
Catania 5
Cesano Boscone 5
Denver 5
Hải Dương 5
Manchester 5
Silistra 5
Vienna 5
Yverdon-les-Bains 5
Bauru 4
Belo Horizonte 4
Brasília 4
Brussels 4
Calgary 4
Dhaka 4
Florence 4
Jeddah 4
Karachi 4
Mauá 4
Miami 4
Mumbai 4
Naples 4
Ottawa 4
Tashkent 4
Amman 3
Asunción 3
Auckland 3
Bengaluru 3
Bishkek 3
Borås 3
Brescia 3
Campinas 3
Caracas 3
Changchun 3
Concord 3
Contagem 3
Totale 2.642
Salva come PNG Salva come JPEG
Nome #
Beauveria bassiana Keratitis: A Case Series and Review of Literature 175
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 123
Anterior segment involvement in vitreoretinal lymphoma: Clinical manifestations, molecular findings and in vivo confocal microscopy 112
Angiopoietin 2 expression in the cornea and its control of corneal neovascularisation 105
A hypothalamic-controlled neural reflex promotes corneal inflammation 101
The Effects of Vitamin D on Keratoconus Progression 101
The role of extracellular matrix in mouse and human corneal neovascularization 99
Corneal and Epidermal Nerve Quantification in Chemotherapy Induced Peripheral Neuropathy 99
Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: An overview of two common animal models of corneal neovascularization 96
Vitamin D Supplementation Impacts Systemic Biomarkers of Collagen Degradation and Copper Metabolism in Patients With Keratoconus 93
Aprepitant Restores Corneal Sensitivity and Reduces Pain in DED 92
Future directions in managing aniridia-associated keratopathy 89
Topical fosaprepitant for the treatment of ocular pain and inflammation 89
Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration 85
VesselJ: a new tool for automatic measurement of corneal neovascularization ex-vivo 85
Corneal collagen cross-linking in paediatric patients affected by keratoconus 83
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series 83
Neurosensory abnormalities and stability of a mouse model of dry eye disease 82
Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndrome 82
Future directions in managing aniridia-associated keratopathy 81
Corneal endothelial cell reduction and increased Neurokinin-1 receptor expression in a graft-versus-host disease preclinical model 78
Safety and Efficacy of Corneal Cross-Linking in Patients Affected by Keratoconus: Long-Term Results 77
Corneal Angiogenesis, Sensitivity, and Visual Acuity: a Retrospective Study 77
A Novel Mouse Model of Acute Ocular Graft-versus-Host Disease 75
Corneal collagen crosslinking and herpetic keratitis Reply 74
The keratoconus enigma: A review with emphasis on pathogenesis 73
Corneal confocal microscopy reveals trigeminal small sensory fiber neuropathy in amyotrophic lateral sclerosis 72
Corneal collagen cross-linking for management of keratoconus in patients affected by Tourette syndrome 72
Double-biguanide therapy for resistant acanthamoeba keratitis 68
Corneal neovascularization and its potential biomarkers in human tears 68
Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study 68
Cultivated limbal epithelial transplantation 66
High Frequency Electrotherapy for the Treatment of Meibomian Gland Dysfunction 66
Substance P/neurokinin-1 receptor pathway blockade ameliorates limbal stem cell deficiency by modulating mTOR pathway and preventing cell senescence 65
Substance P and its Inhibition in Ocular Inflammation 64
Nutritional and Metabolic Imbalance in Keratoconus 63
Erratum: The Effect of Aging on Nerve Morphology and Substance P Expression in Mouse and Human Corneas (Invest Ophthalmol Vis Sci., (2018) 59, (5329-5335), 10.1167/iovs.18-24707) 63
The two-faced effects of nerves and neuropeptides in corneal diseases 61
Substance P aggravates corneal epithelial stem cell deficiency 61
Trigeminal stereotactic electrolysis induces dry eye in mice 61
Trigeminal stereotactic electrolysis induces dry eye in mice 61
Quantifying Ocular Surface Inflammation and Correlating It With Inflammatory Cell Infiltration In Vivo: A Novel Method 61
Modulating ocular surface pain through neurokinin-1 receptor blockade 61
Targeting amyloid-β in glaucoma treatment 61
In vivo confocal microscopy in goldenhar syndrome: a case report 59
Corrigendum to "Corneal innervation as a window to peripheral neuropathies" [Exp. Eye Res. 113 (2013) 148-150] DOI: 10.1016/j.exer.2013.05.016 58
Innovative high-frequency electrotherapy device Rexon-Eye successfully treats Meibomian gland disease patients 57
Topically Applied Neurokinin-1 Receptor Antagonists to Treat Ocular Surface Inflammation 56
Corneal confocal microscopy in non-length-dependent small fiber neuropathy 56
TFOS Lifestyle: Impact of lifestyle challenges on the ocular surface 56
Managing the ocular surface after glaucoma filtration surgery: an orphan topic 55
Substance p modulation of human and murine corneal neovascularization 54
Cell therapy in the cornea: The emerging role of microenvironment 53
Congenital aniridia: European COST action ANIRIDIA-NET guidelines for diagnosis, management and care 53
IN VIVO CORNEAL CONFOCAL MICROSCOPY IN PATIENTS WITH GUILLAIN-BARRE SYNDROME 53
TFOS lifestyle: Impact of lifestyle challenges on the ocular surface 51
NK1 Receptor Antagonists as a New Treatment for Corneal Neovascularization 51
Nerves in the cornea: proper functioning and healing potential 50
Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders 50
Keratoconus: The Local Manifestation of a Systemic Disease? 50
Evaluation of a Post-Operative Therapy Protocol after Epithelium-Off Corneal Cross-Linking in Patients Affected by Keratoconus 50
Topical ranibizumab as a treatment of corneal neovascularization 50
Innovative radiofrequency electrotherapy significantly reduces cornea perforation in an alkali burn murine model 49
Immunity and pain in the eye: focus on the ocular surface 49
Impending corneal perforation after collagen cross-linking for herpetic keratitis 48
Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment 48
Tie2-gfp transgenic mouse as a new model to study corneal neovascularization 47
Reciprocal Inhibition of Nerves and Neovessels in the Cornea 47
Safety and Efficacy of Topical Infliximab in a Mouse Model of Ocular Surface Scarring 47
Topical neurokinin-1 receptor antagonist Fosaprepitant ameliorates ocular graft-versus-host disease in a preclinical mouse model 47
VesselJ: A New Tool for Semiautomatic Measurement of Corneal Neovascularization 46
A novel mouse model for neurotrophic keratopathy: Trigeminal nerve stereotactic electrolysis through the brain 45
Tumor Necrosis Factor-alpha Inhibitors as a Treatment of Corneal Hemangiogenesis and Lymphangiogenesis 45
Topical application of infliximab (Remicade®) in the treatment of corneal caustication 43
Ocular Surface Injury Induces Inflammation in the Brain: In Vivo and Ex Vivo Evidence of a Corneal-Trigeminal Axis 42
Topical formulations of aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration 42
In vivo evaluation of DSAEK interface with scanning-laser confocal microscopy 40
Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation 38
Managing the ocular surface after glaucoma filtration surgery: an orphan topic (Graefe's Archive for Clinical and Experimental Ophthalmology, (2024), 262, 7, (2039-2056), 10.1007/s00417-023-06333-5) 36
Topical interleukin 1 receptor antagonist for treatment of dry eye disease: A randomized clinical trial 30
Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability 28
Bitot's spot in vitamin a deficiency 28
Short-term topical bevacizumab in the treatment of stable corneal neovascularization 26
Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery 25
Corneal neovascularization and the utility of topical VEGF inhibition: Ranibizumab (Lucentis) Vs bevacizumab (Avastin) 25
Chemotherapy-associated peripheral sensory neuropathy assessed using in vivo corneal confocal microscopy 25
Corneal innervation as a window to peripheral neuropathies 24
Trans-scleral delivery of macromolecules 24
In vitro transscleral iontophoresis of high molecular weight neutral compounds 23
Dependence of corneal stem/progenitor cells on ocular surface innervation 21
Laser scanning in vivo confocal microscopy in a case of terrien marginal degeneration 19
Reply 18
In-vitro permeation of bevacizumab through human sclera: Effect of iontophoresis application 16
Nerves and neovessels inhibit each other in the cornea 16
The Impact of Aging and Sex on Corneal Nerve Density and Function 6
The NK-1 Receptor Signaling: Distribution and Functional Relevance in the Eye 2
The Role of Innervation in Ocular Surface Homeostasis, Tissue Remodeling Following Nerve Injury, and the Therapeutic Potential of Hemocomponents in Neuronal and Cicatricial Pathologies † 1
Totale 5.649
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 0 7 0 2 0 7 4 7 0 1
2022/2023215 90 31 10 2 1 13 17 6 6 0 32 7
2023/2024225 0 7 32 43 23 31 8 19 2 10 41 9
2024/20251.004 135 30 17 27 71 62 167 98 168 59 98 72
2025/20264.097 227 262 157 398 544 91 385 304 1.214 207 135 173
2026/202762 62 0 0 0 0 0 0 0 0 0 0 0
Totale 5.649